Coley is the Chief Technology Officer for Wamberg Genomic Advisors (WGA), a company that has launched a first of its kind benefit product, Cancer Guardian. As a product that requires a strong digital experience, Coley oversees all aspects of developing and delivering the platform’s capabilities, bringing innovation, compliance strategies, and deep industry experience together with leading technologies from systems and service providers.
Prior to WGA, Coley held leadership and executive roles at Chord Health, OncoSec Medical, Inovio Biomedical Corporation, Genetronics, Inc., BTX, Abnology, Sangart Inc., Ziff Davis and Harte Hanks Market Intelligence.
As a leader in these cutting-edge organizations, Coley has been involved at the intersection of technology, life sciences, and healthcare for over 20 years. He is passionate about disrupting health care through digital transformations.
Coley has a degree in Finance from the University of New Mexico and was a member of the UNM Football team. He has received certifications from San Diego State University and the Certified Technical Institute (CTI) for Computer Sciences and focused based information technologies. Coley has been involved in the IT community working with the Life Sciences Information Technology Global Institute (LSIT), HIMSS, further promoting and developing industry Good Informatics Practices (GIP) for life sciences and health care companies.